Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1982 1
1983 2
1985 2
1986 2
1987 4
1988 7
1989 24
1990 10
1991 21
1992 18
1993 15
1994 21
1995 46
1996 35
1997 40
1998 50
1999 59
2000 46
2001 47
2002 51
2003 48
2004 33
2005 52
2006 75
2007 80
2008 92
2009 83
2010 83
2011 138
2012 141
2013 133
2014 149
2015 124
2016 153
2017 165
2018 146
2019 160
2020 149
2021 136
2022 149
2023 144
2024 68

Text availability

Article attribute

Article type

Publication date

Search Results

2,742 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Immunodeficiency 96"
Page 1
Antiretroviral Therapy for the Prevention of HIV-1 Transmission.
Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Cottle L, Zhang XC, Makhema J, Mills LA, Panchia R, Faesen S, Eron J, Gallant J, Havlir D, Swindells S, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano DD, Essex M, Hudelson SE, Redd AD, Fleming TR; HPTN 052 Study Team. Cohen MS, et al. N Engl J Med. 2016 Sep 1;375(9):830-9. doi: 10.1056/NEJMoa1600693. Epub 2016 Jul 18. N Engl J Med. 2016. PMID: 27424812 Free PMC article. Clinical Trial.
BACKGROUND: An interim analysis of data from the HIV Prevention Trials Network (HPTN) 052 trial showed that antiretroviral therapy (ART) prevented more than 96% of genetically linked infections caused by human immunodeficiency virus type 1 (HIV-1) in serodiscordant couples …
BACKGROUND: An interim analysis of data from the HIV Prevention Trials Network (HPTN) 052 trial showed that antiretroviral therapy (ART) pre …
Current situation of fungal diseases in Eritrea.
Werkneh S, Orefuwa E, Denning DW. Werkneh S, et al. Mycoses. 2022 Aug;65(8):806-814. doi: 10.1111/myc.13474. Epub 2022 Jun 19. Mycoses. 2022. PMID: 35633079 Free PMC article.
Prevention of HIV Transmission and the HPTN 052 Study.
Cohen MS, Gamble T, McCauley M. Cohen MS, et al. Annu Rev Med. 2020 Jan 27;71:347-360. doi: 10.1146/annurev-med-110918-034551. Epub 2019 Oct 25. Annu Rev Med. 2020. PMID: 31652410 Review.
Trends in TB and HIV care and treatment cascade, Kenya, 2008-2018.
Weyenga H, Onyango E, Katana AK, Pathmanathan I, Sidibe K, Shah NS, Ngugi EW, Waruingi RN, Ng Ang A L, De Cock KM. Weyenga H, et al. Int J Tuberc Lung Dis. 2022 Jul 1;26(7):623-628. doi: 10.5588/ijtld.21.0408. Int J Tuberc Lung Dis. 2022. PMID: 35768918
HOPE in action: A prospective multicenter pilot study of liver transplantation from donors with HIV to recipients with HIV.
Durand CM, Florman S, Motter JD, Brown D, Ostrander D, Yu S, Liang T, Werbel WA, Cameron A, Ottmann S, Hamilton JP, Redd AD, Bowring MG, Eby Y, Fernandez RE, Doby B, Labo N, Whitby D, Miley W, Friedman-Moraco R, Turgeon N, Price JC, Chin-Hong P, Stock P, Stosor V, Kirchner VA, Pruett T, Wojciechowski D, Elias N, Wolfe C, Quinn TC, Odim J, Morsheimer M, Mehta SA, Rana MM, Huprikar S, Massie A, Tobian AAR, Segev DL; HOPE in Action Investigators. Durand CM, et al. Am J Transplant. 2022 Mar;22(3):853-864. doi: 10.1111/ajt.16886. Epub 2021 Nov 25. Am J Transplant. 2022. PMID: 34741800 Free PMC article.
We quantified patient survival, graft survival, rejection, serious adverse events (SAEs), human immunodeficiency virus (HIV) breakthrough, infections, and malignancies, using Cox and negative binomial regression with inverse probability of treatment weighting. ...
We quantified patient survival, graft survival, rejection, serious adverse events (SAEs), human immunodeficiency virus (HIV) breakthr …
Interleukin-2 as an adjunct to antiretroviral therapy for HIV-positive adults.
Onwumeh J, Okwundu CI, Kredo T. Onwumeh J, et al. Cochrane Database Syst Rev. 2017 May 25;5(5):CD009818. doi: 10.1002/14651858.CD009818.pub2. Cochrane Database Syst Rev. 2017. PMID: 28542796 Free PMC article. Review.
BACKGROUND: Human immunodeficiency virus (HIV) continues to be a leading cause of morbidity and mortality, particularly in sub-Saharan Africa. ...
BACKGROUND: Human immunodeficiency virus (HIV) continues to be a leading cause of morbidity and mortality, particularly in sub-Sahara …
2,742 results